Characterizing antidepressant-like effects of a novel peptide HCN channel inhibitor

表征新型肽 HCN 通道抑制剂的抗抑郁样作用

基本信息

  • 批准号:
    9322763
  • 负责人:
  • 金额:
    $ 15.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2017-11-29
  • 项目状态:
    已结题

项目摘要

Major depressive disorder (MDD) affects millions of people worldwide. Most drugs available to treat MDD target brain pathways involving monoaminergic neurotransmitters. Because up to fifty percent of patients do not improve in response to existing therapies, new treatments that target novel mechanisms are needed. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels mediate Ih, an important current for controlling neuronal excitability. Brain HCN channels are tightly regulated by an auxiliary subunit, TRIP8b (tetratricopeptide repeat-containing Rab8b-interacting protein). Animals lacking TRIP8b and other HCN subunits exhibit an antidepressant-like phenotype, suggesting that inhibiting HCN channels could effectively treat depression. Because the channels are critical in controlling heart rate, directly targeting HCN channels throughout the body is not a viable therapeutic approach. We recently demonstrated that viral overexpression of TRIP8b in the hippocampus leads to changes in HCN channel function with concomitant changes in behaviors associated with antidepressant use. In particular, restoring TRIP8b expression in the hippocampi of TRIP8b knockout mice promoted depression- like behaviors, while a version of TRIP8b with impaired binding to HCN channel pore-forming subunits increased antidepressant-like behavior. These results indicate that the TRIP8b-HCN interaction might be a novel pharmacological target for treating MDD. Although our recent studies with viral gene therapy strengthen the evidence that inhibiting brain HCN might be useful for depression treatment, the approach requires surgery and the technology is not readily translatable to human patients with MDD. On the other hand, inhibitors of the TRIP8b-HCN interaction offer increased ease of use in probing the role of HCN channels in behavior as well as greater translatability as potential therapies. Along theses lines, we have synthesized a small (11 amino acids) peptide capable of binding TRIP8b and blocking the TRIP8b-HCN interaction in vitro. A cell permeable version of this peptide (SNL-CP) was synthesized to allow the peptide to penetrate the blood-brain barrier and cell membranes. In preliminary studies, we show that SNL-CP crosses the plasma membrane of CA1 neurons. We hypothesize that peptide mediated inhibition of TRIP8b's interaction with HCN pore-forming subunits will promote antidepressant-like behavior. In aim 1, we will assess the ability of SNL-CP to disrupt the TRIP8b-HCN interaction after chronic intrahippocampal delivery in mice. These experiments will determine the dosing strategy necessary for therapeutic intervention. In aim 2, we will evaluate the ability of SNL-CP to promote antidepressant-like behavior in mice. The work described in this proposal will evaluate a novel approach to producing antidepressant-like behaviors in mice and could pave the way for a new approach to treating MDD in human patients refractory to existing therapies.
重度抑郁症(MDD)影响着全世界数百万人。大多数可用于治疗MDD的药物 靶向涉及单胺能神经递质的脑通路。因为百分之五十的病人 虽然现有疗法的效果没有改善,但针对新机制的新疗法正在 needed.超极化激活的环核苷酸门控(HCN)通道介导Ih,一种重要的 控制神经元兴奋性的电流。大脑HCN通道由一种辅助的 TRIP8b(tetratricopeptide repeat-containing Rab8b-interacting protein)。缺乏TRIP 8b的动物 和其他HCN亚基表现出抗抑郁样表型,这表明抑制HCN通道 可以有效治疗抑郁症。因为这些通道在控制心率方面至关重要, 针对全身的HCN通道并不是一种可行的治疗方法。我们最近 证明海马中TRIP 8b的病毒过表达导致HCN的变化, 通道功能与抗抑郁药使用相关行为的伴随变化。在 特别是,恢复TRIP 8b基因敲除小鼠大脑中TRIP 8b的表达促进了抑郁症的发生。 类似的行为,而TRIP 8b与HCN通道孔形成亚基结合受损的版本 增加抗抑郁症样行为。这些结果表明,TRIP 8b-HCN相互作用可能是一个重要的机制。 用于治疗MDD的新的药理学靶点。 尽管我们最近的病毒基因治疗研究加强了抑制脑HCN可能 对于抑郁症的治疗是有用的,这种方法需要手术,而且技术不容易 可以转化为患有MDD的人类患者。另一方面,TRIP 8b-HCN相互作用的抑制剂提供 在探测HCN通道在行为中的作用方面增加了易用性, 潜在的治疗沿着这些路线,我们已经合成了一种小的(11个氨基酸)肽,能够 在体外结合TRIP 8b并阻断TRIP 8b-HCN相互作用。这种肽的细胞渗透版本 合成SNL-CP以允许肽穿透血脑屏障和细胞膜。在 初步研究表明,SNL-CP穿过CA 1神经元的质膜。我们 假设肽介导TRIP 8b与HCN孔形成相互作用的抑制 亚基将促进抗抑郁样行为。在目标1中,我们将评估SNL-CP的能力, 在小鼠中慢性海马内递送后破坏TRIP 8b-HCN相互作用。这些实验将 确定治疗干预所需的给药策略。在目标2中,我们将评估 SNL-CP促进小鼠的抗抑郁样行为。本提案中所述的工作将评估 一种在小鼠中产生抗抑郁样行为的新方法, 在对现有疗法难治的人类患者中治疗MDD的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dane M Chetkovich其他文献

Dane M Chetkovich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dane M Chetkovich', 18)}}的其他基金

Development of in vivo probes to study the function of TRIP8b in cognition
开发体内探针来研究 TRIP8b 在认知中的功能
  • 批准号:
    10644201
  • 财政年份:
    2022
  • 资助金额:
    $ 15.45万
  • 项目类别:
Development of in vivo probes to study the function of TRIP8b in cognition
开发体内探针来研究 TRIP8b 在认知中的功能
  • 批准号:
    10665810
  • 财政年份:
    2022
  • 资助金额:
    $ 15.45万
  • 项目类别:
Investigating the Role of the Dorsal Hippocampus to Nucleus Accumbens Pathway in Regulating Social Interaction
研究背侧海马到伏核通路在调节社会互动中的作用
  • 批准号:
    10381577
  • 财政年份:
    2021
  • 资助金额:
    $ 15.45万
  • 项目类别:
Investigating the Role of the Dorsal Hippocampus to Nucleus Accumbens Pathway in Regulating Social Interaction
研究背侧海马到伏核通路在调节社会互动中的作用
  • 批准号:
    10195843
  • 财政年份:
    2021
  • 资助金额:
    $ 15.45万
  • 项目类别:
Characterizing antidepressant-like effects of a novel peptide HCN channel inhibitor
表征新型肽 HCN 通道抑制剂的抗抑郁样作用
  • 批准号:
    9617909
  • 财政年份:
    2018
  • 资助金额:
    $ 15.45万
  • 项目类别:
Discovery of novel small molecule antidepressants
新型小分子抗抑郁药的发现
  • 批准号:
    9263004
  • 财政年份:
    2016
  • 资助金额:
    $ 15.45万
  • 项目类别:
Discovery of novel small molecule antidepressants
新型小分子抗抑郁药的发现
  • 批准号:
    9038165
  • 财政年份:
    2016
  • 资助金额:
    $ 15.45万
  • 项目类别:
Evaluation of antidepressant-like effects of hippocampal HCN channel modulation
海马 HCN 通道调节的抗抑郁样作用评价
  • 批准号:
    8824404
  • 财政年份:
    2014
  • 资助金额:
    $ 15.45万
  • 项目类别:
Evaluation of antidepressant-like effects of hippocampal HCN channel modulation
海马 HCN 通道调节的抗抑郁样作用评价
  • 批准号:
    8923343
  • 财政年份:
    2014
  • 资助金额:
    $ 15.45万
  • 项目类别:
Role of TRIP8b in epilepsy
TRIP8b 在癫痫中的作用
  • 批准号:
    8192017
  • 财政年份:
    2011
  • 资助金额:
    $ 15.45万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了